Preventing type 2 diabetes with low-dose combinations (Q42982905)

12 November 2017

title

Preventing type 2 diabetes with low-dose combinations (English)

1 reference

12 November 2017

1 reference

Thomas A Buchanan

1

1 reference

12 November 2017

Anny H Xiang

series ordinal

2

1 reference

12 November 2017

language of work or name

English

0 references

publication date

3 June 2010

1 reference

12 November 2017

1 reference

12 November 2017

volume

376

1 reference

12 November 2017

issue

9735

1 reference

12 November 2017

page(s)

72-74

1 reference

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960900-2

7 January 2021

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960900-2

7 January 2021

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960900-2

7 January 2021

Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960900-2

7 January 2021

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960900-2

7 January 2021

XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960900-2

7 January 2021

(How) can we prevent type 2 diabetes?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960900-2

7 January 2021

Effect of valsartan on the incidence of diabetes and cardiovascular events

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960900-2

7 January 2021

Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960900-2

7 January 2021

A Double Antibody Immunoassay for Glucagon

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960900-2

7 January 2021

Effect of pioglitazone on pancreatic beta-cell function and diabetes risk in Hispanic women with prior gestational diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960900-2

7 January 2021

10.1016/S0140-6736(10)60900-2

Identifiers

DOI

1 reference

12 November 2017

1 reference